(Q72871989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Predicting recurrence in axillary-node negative breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

D Rosner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

W W Lane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

127-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00662138

29 October 2019

exact match

0 references

cites work

Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy

1 reference

12 December 2020

Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy

1 reference

12 December 2020

Leukemia following chemotherapy for breast cancer.

1 reference

12 December 2020

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma

1 reference

12 December 2020

Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer

1 reference

12 December 2020

Adjuvant therapy for node-negative breast cancer

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

12 December 2020

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

1 reference

12 December 2020

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

12 December 2020

The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy

1 reference

12 December 2020

Prognostic significance of DNA measurements in 409 consecutive breast cancer patients

1 reference

12 December 2020

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

12 December 2020

Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study

1 reference

12 December 2020

Predictors of recurrence and survival of patients with breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Evaluating quality and quantity of life in breast cancer adjuvant trials

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy

1 reference

12 December 2020

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

12 December 2020

Validity of the clinical alert on breast cancer

1 reference

12 December 2020

Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons

1 reference

12 December 2020

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

1 reference

12 December 2020

Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count

1 reference

12 December 2020

Breast cancer and acute leukemia: Report of 24 cases and review of the literature

1 reference

12 December 2020

Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture

1 reference

12 December 2020

Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure

1 reference

12 December 2020

Ductal carcinomain situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy

1 reference

12 December 2020

The importance of DNA flow cytometry in node-negative breast cancer

1 reference

12 December 2020

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

12 December 2020

Systemic Adjuvant Therapy in Women With Resected Node-Negative Breast Cancer

1 reference

12 December 2020

Adjuvant therapy in node-negative breast cancer. A panel discussion

1 reference

12 December 2020

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

12 December 2020

Prognosis and treatment decisions in patients with breast cancer without axillary node involvement

1 reference

12 December 2020

An improved technique for the study of lymph nodes in surgical specimens

1 reference

12 December 2020

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

12 December 2020

Breast cancer therapy: exercising all our options

1 reference

12 December 2020

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

12 December 2020

Update of the Swedish two-county program of mammographic screening for breast cancer

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group

1 reference

12 December 2020

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

12 December 2020

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients

1 reference

12 December 2020

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

12 December 2020

Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group

1 reference

12 December 2020

How to use prognostic factors in axillary node-negative breast cancer patients

1 reference

12 December 2020

Meeting Highlights: Adjuvant Therapy for Breast Cancer

1 reference

12 December 2020

Adjuvant therapy of node-negative breast cancer

1 reference

12 December 2020

Quality of life in stage II breast cancer: an instrument for clinical trials.

1 reference

12 December 2020

Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery alone

1 reference

12 December 2020

Cathepsin D and prognosis in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00662138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347845%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference